![PRD_000762 PRD_000762](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000762.svg) | PRD_000762 | Name: | METHANOBACTIN MB-OB3B | Formula: | C45 H56 Cu N10 O16 S5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000764 PRD_000764](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000764.svg) | PRD_000764 | Name: | CYCLOSPORIN D, 5,7 mutation | Formula: | C64 H117 N11 O12 S | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED IN DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL).
THE CYCLOSPORIN D MOLECULE WAS MODIFIED AT
POSITIONS 5 AND 7 TO BE
(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE AND
(2-S-METHYL)-SARCOSINE, RESPECTIVELY. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000765 PRD_000765](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000765.svg) | PRD_000765 | Name: | CYCLOSPORIN A, 5 mutation | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN WAS MODIFIED AT POSITION 5 TO BE
4-[(E)-2-BUTENYL]-4,4,N-TRIMETHYL-L-THREONINE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000766 PRD_000766](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000766.svg) | PRD_000766 | Name: | CYCLOSPORIN A, 6 mutation | Formula: | C63 H113 N11 O13 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 6 TO BE 2-AMINO-5-HYDROXYPENTANOIC ACID | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000767 PRD_000767](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000767.svg) | PRD_000767 | Name: | CYCLOSPORIN A, 7 mutation | Formula: | C63 H113 N11 O13 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A WAS MODIFIED AT POSITION 7
TO BE N-METHYL-D-SERINE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000768 PRD_000768](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000768.svg) | PRD_000768 | Name: | CYCLOSPORIN A, 8 mutation | Formula: | C62 H111 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 8 TO BE N-METHYL-ISOLEUCINE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_002426 PRD_002426](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002426.svg) | PRD_002426 | Name: | Corramycin | Formula: | C51 H81 N11 O21 | Definition date: | 2023-08-16 | Last modified: | 2023-08-16 |
|
![PRD_002432 PRD_002432](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002432.svg) | PRD_002432 | Name: | Pam3-SKKKK | Formula: | C81 H160 N10 O13 S | Definition date: | 2023-07-12 | Last modified: | 2023-07-12 |
|
![PRD_002528 PRD_002528](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002528.svg) | PRD_002528 | Name: | 142D6 | Formula: | C26 H37 F N4 O6 S | Description: | Lys-covalent pan-IAP inhibitor | Definition date: | 2023-07-12 | Last modified: | 2023-07-12 |
|
![PRD_002527 PRD_002527](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002527.svg) | PRD_002527 | Name: | Intermediate for maxamycins synthesis | Formula: | C84 H114 Cl2 N8 O17 S Si2 | Definition date: | 2023-07-05 | Last modified: | 2023-07-05 |
|
![PRD_002431 PRD_002431](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002431.svg) | PRD_002431 | Name: | Cyclic tetraadenosine monophosphate (cA4) | Formula: | C40 H48 N20 O24 P4 | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | Definition date: | 2023-07-12 | Last modified: | 2023-07-03 |
|
![PRD_001065 PRD_001065](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001065.svg) | PRD_001065 | Name: | teicoplanin | Formula: | C88 H97 Cl2 N9 O34 | Definition date: | 2013-05-29 | Last modified: | 2023-06-11 |
|
![PRD_002268 PRD_002268](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002268.svg) | PRD_002268 | Name: | Lipid II | Formula: | C54 H91 N8 O26 P2 | Definition date: | 2020-08-19 | Last modified: | 2023-06-11 |
|
![PRD_002330 PRD_002330](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002330.svg) | PRD_002330 | Name: | Darobactin | Formula: | C47 H56 N11 O12 | Definition date: | 2021-04-21 | Last modified: | 2023-06-11 |
|
![PRD_002342 PRD_002342](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002342.svg) | PRD_002342 | Formula: | C51 H66 N14 O11 | Definition date: | 2022-04-06 | Last modified: | 2023-06-11 |
|
![PRD_002346 PRD_002346](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002346.svg) | PRD_002346 | Name: | Inhibitor ARC-3126 | Formula: | C58 H108 Br N31 O9 S | Definition date: | 2021-08-04 | Last modified: | 2023-06-11 |
|
![PRD_002353 PRD_002353](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002353.svg) | PRD_002353 | Name: | Blood group B type 1 antigen, beta anomer | Formula: | C26 H45 N O20 | Definition date: | 2022-03-02 | Last modified: | 2023-06-11 |
|
![PRD_002470 PRD_002470](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002470.svg) | PRD_002470 | Name: | Agrocinopine A (alpha-L-arabinopyranose form) | Formula: | C17 H31 O18 P | Description: | phosphodiester of sucrose and L-arabinose | Definition date: | 2023-05-24 | Last modified: | 2023-05-24 |
|
![PRD_002441 PRD_002441](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002441.svg) | PRD_002441 | Name: | Myxovalargin B | Formula: | C80 H136 N21 O17 | Definition date: | 2023-01-25 | Last modified: | 2023-05-11 |
|
![PRD_002442 PRD_002442](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002442.svg) | PRD_002442 | Name: | Myxovalargin A | Formula: | C81 H138 N21 O17 | Definition date: | 2023-01-18 | Last modified: | 2023-05-11 |
|
![PRD_002366 PRD_002366](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002366.svg) | PRD_002366 | Name: | Phalloidin | Formula: | C35 H48 N8 O11 S | Definition date: | 2021-12-22 | Last modified: | 2023-05-09 |
|
![PRD_002419 PRD_002419](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002419.svg) | PRD_002419 | Name: | Cyclomarin A | Formula: | C56 H82 N8 O11 | Definition date: | 2023-03-29 | Last modified: | 2023-03-29 |
|
![PRD_002516 PRD_002516](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002516.svg) | PRD_002516 | Name: | cyclic peptide inhibitor 1 | Formula: | C111 H132 N23 O30 S | Definition date: | 2023-03-22 | Last modified: | 2023-03-22 |
|
![PRD_002425 PRD_002425](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002425.svg) | PRD_002425 | Name: | Drosocin | Formula: | C98 H166 N34 O24 | Definition date: | 2023-03-08 | Last modified: | 2023-03-08 |
|
![PRD_002526 PRD_002526](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002526.svg) | PRD_002526 | Name: | DFFR-chloromethyl ketone inhibitor | Formula: | C25 H34 N6 O3 | Definition date: | 2023-02-22 | Last modified: | 2023-02-22 |
|